AirDuo Respiclick is a new combination maintenance inhaler that will be available soon. AirDuo Respiclick was recently FDA approved and it is indicated for the treatment of asthma in patients 12 years and older. The ingredients in AirDuo Respiclick are the same as Advair, but in slightly different dosages. The ingredients are; fluticasone propionate inhalation […]
Chronic Sinusitis and Depression leads to lost productivity
Chronic sinusitis is an inflammatory diseases of the sinus mucosa that causes a significant decrease in quality of life. The quality of life detriment is comparable or worse than other chronic diseases such as asthma and cardiac disease. Chronic sinusitis has been associated with depression, decreased cognitive function, anxiety and diminished sleep. Chronic sinusitis is […]
Generic Advair Availability is Delayed
Update January 30, 2019 The FDA just approved generic Advair and it should be available in the coming weeks. Mylan has not indicated the price on it yet but the hope is that it will be significantly cheaper than the branded version. It is anticipated that insurance companies will now require for patients to use […]
Nemolizumab for Itching and Atopic Dermatitis
Nemolizumab is a new medication being currently developed by Chugai Pharmaceutical Company. It will be licensed and developed by Galderma Pharma who picked up the rights to it. With the recent ground breaking FDA approval of Dupixent (dupilumab) for eczema, this will help many patients suffering itchy, inflamed dry skin. As with all new biological […]
Egg Allergy Prevention
Preventing food allergies has been shown to be effective by an early introduction to foods rather than a delayed introduction. The recent new of preventing peanut allergy. Peanut Allergy Prevention, has scientists looking into other foods as well. Egg allergy prevention was recently investigated and published in the Lancet. Researchers studied whether a stepwise early introduction of […]
Odactra Sublingual House Dust Mite Allergen Approved by FDA
Odactra the first sublingual house dust mite allergen, has been approved by the FDA. Odactra will be administered under the tongue and it is used to treat house dust mite induced perennial allergic rhinitis and/or allergic conjunctivitis for adults 18-65 years of age. House dust mite is one of the most common perennial aeroallergens affecting […]
Spiriva Respimat for Add-on Asthma
Spiriva Respimat is an add on therapy for patients who have uncontrolled asthma. It is approved for patients aged 12 and up who are already taking an inhaled corticosteroid or an inhaled corticosteroid plus a long acting beta-agonist, such as Advair, Dulera, Symbicort or Breo. Spiriva Respimat (tiotropium) can be used as add-on therapy for […]
Xyzal OTC to be available March 2017
Xyzal OTC will soon be available without a prescription March 2017. In a growing trend in the allergy pharmaceutical market, most prescription medications are now becoming over the counter. Xyzal (generic brand name is levoceterizine) received FDA approval earlier this month for treatment for the relief of symptoms of seasonal and year round allergies. The […]
Coconut Allergy in Relation to Tree Nuts
Many patients who have tree nut allergy wonder if they have coconut allergy as well. That goes more to the question, is coconut a tree nut? Coconut is actually a fruit, but the US FDA classifies coconut as a tree nut. There has been little guidance in patients with tree nut allergies on the safety […]
New California Epinephrine Law for 2017
In 2017, a new California Epinephrine Law went into effect. Businesses and public agencies in California are now defined as “authorized entities, are allowed to keep epinephrine auto injectors on hand to help treat emergency allergic reactions.”. Liability and professional review protections remain in place for physicians issuing a prescription or order for epinephrine auto […]










